Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Potent, broad-spectrum, orally bioavailable carbapenems designed by Sankyo

Nov. 12, 1999

Bristol-Myers Squibb begins phase II testing of inlicensed quinolone

Nov. 12, 1999

New data reported for Tamiflu as influenza treatment and prophylaxis

Nov. 10, 1999

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

Nov. 8, 1999

Potential interaction between S-4661 and valproic acid

Nov. 8, 1999

Antiviral agents discovered at U. of Michigan

Nov. 8, 1999

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Nov. 8, 1999

Large clinical trial to evaluate AG-7088 nasal spray as a common cold remedy commences

Nov. 5, 1999

Novel inhibitors of multidrug transporter mediating fluoroquinolone efflux

Nov. 5, 1999

Breakthrough flu treatment approved by Health Canada

Nov. 5, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026